This recent article by Prof. Alok Bhattacharya and Dr. Gayatri Saberwal in The Hindu highlights a critical gap: without strong investment in basic science and India-specific patient data, true innovation will remain out of reach. From rare diseases to precision medicine, breakthroughs begin with understanding biology, not just manufacturing solutions.
If we want the next generation of cures to be designed in India, we must start by funding the science that makes them possible.
Read full article here
